This report contains market size and forecasts of Home Insulin Delivery (Dosing) Devices in global, including the following market information:
Global Home Insulin Delivery (Dosing) Devices Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Home Insulin Delivery (Dosing) Devices Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Home Insulin Delivery (Dosing) Devices companies in 2021 (%)
The global Home Insulin Delivery (Dosing) Devices market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Insulin Pens Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Home Insulin Delivery (Dosing) Devices include Tandem Diabetes Care, Biocon, Roche Holding AG, Insulet Corporation, B. Braun, BD, Eli Lilly and Company, Novo Nordisk and Sanofi, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Home Insulin Delivery (Dosing) Devices manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Home Insulin Delivery (Dosing) Devices Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Home Insulin Delivery (Dosing) Devices Market Segment Percentages, by Type, 2021 (%)
Insulin Pens
Insulin Pumps
Insulin Syringes
Others
Global Home Insulin Delivery (Dosing) Devices Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Home Insulin Delivery (Dosing) Devices Market Segment Percentages, by Application, 2021 (%)
Hospitals Pharmacy
Online Pharmacy
Retail Pharmacy
Global Home Insulin Delivery (Dosing) Devices Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Home Insulin Delivery (Dosing) Devices Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Home Insulin Delivery (Dosing) Devices revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Home Insulin Delivery (Dosing) Devices revenues share in global market, 2021 (%)
Key companies Home Insulin Delivery (Dosing) Devices sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Home Insulin Delivery (Dosing) Devices sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Tandem Diabetes Care
Biocon
Roche Holding AG
Insulet Corporation
B. Braun
BD
Eli Lilly and Company
Novo Nordisk
Sanofi
Wockhardt
Ypsomed Holding
Medtronic
Julphar
Beta Bionics
Copernicus
Dance Biopharm
Debiotech
MannKind
Owen Mumford
SOOIL
Valeritas
West Pharma